MAY[removed]IKhbc[removed]k) Summary

First Page		Document Content
Date: 2014-06-06 11:54:26 Technology Neurotechnology Pharmaceutical industry Clinical research Pharmaceuticals policy Medical device Federal Food Drug and Cosmetic Act Premarket approval Spinal cord stimulator Medicine Food and Drug Administration Health		MAY[removed]IKhbc[removed]k) Summary Add to Reading List Source URL: www.accessdata.fda.gov Download Document from Source Website File Size: 181,73 KB Share Document on Facebook

	Aleva Neurotherapeutics and Greatbatch, Inc. Collaborate on NextGeneration Device for Deep Brain Stimulation (DBS) - Agreement includes strategic investment in Aleva’s current Series C round by Greatbatch, Inc. Lausann DocID: 1qiqV - View Document
	Electromedical Devices: Use in pain management and injury-related complications The high prevalence of chronic pain and the increasing awareness of the risks associated with medications used to treat pain, particularly o DocID: 1q2yi - View Document
	Aleva Neurotherapeutics Raises USD 18 Million in Series C Financing Round - Greatbatch, Inc. acts as strategic lead investor – Lausanne, Switzerland, May 27, 2016 – Aleva Neurotherapeutics, a leading company developi DocID: 1pBAK - View Document
	Why do we need improved mobility technology? DocID: 1pu9w - View Document
	Microsoft Word - Zbornik_v03.doc DocID: 1oO7e - View Document